Efficacy of azithromycin in severe asthma from the AMAZES randomised trial

BACKGROUND: Low-dose azithromycin is an effective therapy for persistent asthma; however, its benefit in severe asthma is not defined. METHODS: Participants with severe asthma were identified from the AMAZES randomised, placebo-controlled trial of long-term (48 weeks) low-dose azithromycin. Particip...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibson, Peter G., Yang, Ian A., Upham, John W., Reynolds, Paul N., Hodge, Sandra, James, Alan L., Jenkins, Christine, Peters, Matthew J., Marks, Guy B., Baraket, Melissa, Powell, Heather, Simpson, Jodie L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6926362/
https://www.ncbi.nlm.nih.gov/pubmed/31886156
http://dx.doi.org/10.1183/23120541.00056-2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6926362/
https://www.ncbi.nlm.nih.gov/pubmed/31886156
http://dx.doi.org/10.1183/23120541.00056-2019

Ejemplares similares